Vanderbilt researchers have established a link between the neurotransmitter serotonin and certain behaviors of some children with autism spectrum disorder (ASD), a link that may lead to new treatments for ASD.

Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.

Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.

Treating depressed individuals and figuring out who will and won’t respond to antidepressants is mostly trial and error — much to the frustration of patients and the health care providers who treat them.

Functional magnetic resonance imaging has revealed faulty circuits between the thalamus – a central hub of brain activity – and other brain regions.

Many women who receive chemotherapy for breast cancer report problems with their thinking, memory and attention after treatment.

Vanderbilt investigators report the first use of a specialized type of MRI to study the hippocampus in patients with schizophrenia.